X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
antiretroviral therapy (9) 9
humans (9) 9
medicine (9) 9
female (8) 8
hiv (8) 8
human immunodeficiency virus (8) 8
index medicus (8) 8
male (8) 8
adult (7) 7
aids (7) 7
antiretroviral agents (7) 7
antiretroviral drugs (7) 7
human immunodeficiency virus--hiv (7) 7
infectious diseases (7) 7
middle aged (7) 7
mortality (7) 7
multidisciplinary sciences (7) 7
research article (7) 7
science (7) 7
acquired immune deficiency syndrome (6) 6
acquired immune deficiency syndrome--aids (6) 6
epidemiology (6) 6
highly active antiretroviral therapy (6) 6
hiv infection (6) 6
hiv infections - drug therapy (6) 6
medical research (6) 6
morbidity (6) 6
anti-hiv agents - therapeutic use (5) 5
c-reactive protein (5) 5
clinical trials (5) 5
health aspects (5) 5
interleukin (5) 5
interleukin 6 (5) 5
medicine, experimental (5) 5
risk (5) 5
viral diseases (5) 5
antiviral agents (4) 4
biomarkers (4) 4
biomarkers - blood (4) 4
clinical research design (4) 4
health risks (4) 4
hepatitis (4) 4
hiv patients (4) 4
infections (4) 4
inflammation (4) 4
interleukin-6 - blood (4) 4
interleukins (4) 4
risk factors (4) 4
therapy (4) 4
adults (3) 3
association (3) 3
biology (3) 3
cardiovascular disease (3) 3
cardiovascular diseases (3) 3
coagulation (3) 3
coronary-heart-disease (3) 3
death (3) 3
drug therapy (3) 3
gastroenterology and hepatology (3) 3
glomerular-filtration-rate (3) 3
hiv infections - blood (3) 3
hiv infections - complications (3) 3
hiv infections - mortality (3) 3
interleukin-6 (3) 3
kidney diseases (3) 3
liver (3) 3
liver diseases (3) 3
rna (3) 3
610 medicine & health (2) 2
age factors (2) 2
analysis (2) 2
antiretroviral therapy, highly active (2) 2
biochemistry (2) 2
biomarker epidemiology (2) 2
c-reactive protein - metabolism (2) 2
cancer (2) 2
care and treatment (2) 2
case-control studies (2) 2
cause of death (2) 2
cd4 antigen (2) 2
cd4 lymphocyte count (2) 2
clinic for infectious diseases (2) 2
confidence intervals (2) 2
diabetes (2) 2
disease (2) 2
drugs (2) 2
end-stage renal disease (2) 2
exposure (2) 2
fibrin fibrinogen degradation products - metabolism (2) 2
follow-up studies (2) 2
genitourinary infections (2) 2
hepatitis b (2) 2
hepatitis b virus (2) 2
hiv epidemiology (2) 2
hiv seropositivity - drug therapy (2) 2
human-immunodeficiency-virus (2) 2
hyaluronic acid (2) 2
individuals (2) 2
life expectancy (2) 2
logistic models (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 2012, Volume 7, Issue 9, p. e44454
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2013, Volume 8, Issue 2, p. e56249
Background: Despite advances in HIV treatment, bacterial pneumonia continues to cause considerable morbidity and mortality in patients with HIV infection.... 
C-REACTIVE PROTEIN | COMMUNITY-ACQUIRED PNEUMONIA | STATIN THERAPY | MULTIDISCIPLINARY SCIENCES | ACTIVE ANTIRETROVIRAL THERAPY | DISEASE | ALPHA | SERUM | COHORT | HUMAN-IMMUNODEFICIENCY-VIRUS | HOSPITALIZATION | Fibrin Fibrinogen Degradation Products | HIV Infections - blood | Pneumonia, Bacterial - blood | C-Reactive Protein | Humans | Middle Aged | Pneumonia, Bacterial - etiology | Risk Factors | Pulmonary Surfactant-Associated Protein D - blood | Male | Pneumonia, Bacterial - virology | Biomarkers - blood | Pneumonia, Bacterial - diagnosis | Case-Control Studies | Uteroglobin - blood | Lung - virology | Interleukin-6 - blood | HIV Infections - complications | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Medical research | Antiviral agents | Care and treatment | Pneumonia | C-reactive protein | AIDS treatment | Bacterial pneumonia | Mortality | HIV patients | HIV (Viruses) | Risk factors | Infection control | Highly active antiretroviral therapy | Control | Surface active agents | Interleukins | Medicine, Experimental | Biological markers | Health aspects | HIV infection | Cases | Therapy | Interleukin | Critical care | Risk | Systematic review | Infections | Family medical history | Interleukin 6 | Proteins | Hepatitis | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Bacteria | Tumor necrosis factor-TNF | Chronic obstructive pulmonary disease | Hepatitis B virus | Drug therapy | Antiretroviral drugs | Statistical analysis | Diabetes mellitus | Health risks | Protein D | Inflammation | Gene expression | Patients | Antiretroviral therapy | Morbidity | CD4 antigen | Infectious diseases | Surfactant protein D | Biomarkers | Hepatitis B | Smoking | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2013, Volume 8, Issue 7, p. e69266
Background: Non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant mutants have been shown to emerge after interruption of suppressive NNRTI-based... 
INFECTED INDIVIDUALS | HIV | VARIANTS | MULTIDISCIPLINARY SCIENCES | EFAVIRENZ | REGIMEN | NEVIRAPINE | ASSOCIATION | DRUG-RESISTANCE MUTATIONS | INTERRUPTION | PLASMA PHARMACOKINETICS | Anti-Retroviral Agents - therapeutic use | Reverse Transcriptase Inhibitors - blood | Humans | Middle Aged | Logistic Models | Male | Chromatography, High Pressure Liquid | HIV-1 - genetics | Nevirapine - blood | Drug Resistance, Viral - genetics | DNA Mutational Analysis | Adult | Benzoxazines - blood | Female | HIV Infections - drug therapy | High-Throughput Nucleotide Sequencing | Reverse Transcriptase Inhibitors - therapeutic use | Odds Ratio | Highly active antiretroviral therapy | Antiviral agents | Medical research | Analysis | Nucleosides | Medicine, Experimental | DNA polymerases | Biological products industry | Nucleotide sequencing | High performance liquid chromatography | DNA sequencing | Drugs | Therapy | RNA-directed DNA polymerase | Nevirapine | Viremia | Population studies | Drug resistance | Efavirenz | Confidence intervals | Restarting | Rams | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Antiretroviral drugs | Interruption | Liquid chromatography | High-performance liquid chromatography | Patients | Antiretroviral therapy | Mutants | Inhibitors | Protease inhibitors | Mutation | Acquired immune deficiency syndrome | AIDS | Human immunodeficiency virus
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2014, Volume 9, Issue 3, p. e90978
Journal Article
PLoS Medicine, ISSN 1549-1277, 10/2008, Volume 5, Issue 10, pp. 1496 - 1508
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2014, Volume 9, Issue 4, p. e95061
Journal Article